Cargando…
Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer
BACKGROUND: Since the beginning of the COVID-19 pandemic, multiple changes to the provision of cancer care has been introduced to maximize patient safety and protect staff. We aimed to identify factors influencing clinicians’ decision on treatment modification during the initial phase of the pandemi...
Autores principales: | Kamposioras, Konstantinos, Lim, Kok Haw Jonathan, Williams, Joseph, Alani, Mohammed, Barriuso, Jorge, Collins, Joanne, Marti, Kalena, Braun, Michael, Mullamitha, Saifee, Hasan, Jurjees, Alam, Nooreen, Mahmood, Sophina, Finch, Spencer, Bayles, Lauren, King, Jennifer, Saunders, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632436/ https://www.ncbi.nlm.nih.gov/pubmed/34953674 http://dx.doi.org/10.1016/j.clcc.2021.11.010 |
Ejemplares similares
-
The Impact of Changes in Service Delivery in Patients With Colorectal Cancer During the Initial Phase of the COVID-19 Pandemic
por: Kamposioras, Konstantinos, et al.
Publicado: (2021) -
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM Study
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2023) -
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
por: Jayson, Gordon C., et al.
Publicado: (2018) -
Biomarker concordance between primary colorectal cancer and its metastases
por: Bhullar, D.S., et al.
Publicado: (2019) -
Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme
por: Iveson, Timothy, et al.
Publicado: (2020)